Otsuka Holdings
4578.T
#665
Rank
โ‚น3.785 T
Marketcap
โ‚น7,204
Share price
-3.26%
Change (1 day)
53.60%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: โ‚น100.32 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are โ‚น14.47 Billion. In 2023 the company made an earning of โ‚น100.32 Billion a decrease over its 2022 earnings that were of โ‚น126.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023โ‚น100.32 B-20.93%
2022โ‚น126.87 B-12.7%
2021โ‚น145.33 B-19.92%
2020โ‚น181.49 B13.9%
2019โ‚น159.34 B52.07%
2018โ‚น104.78 B11.22%
2017โ‚น94.21 B-36.03%
2016โ‚น147.27 B31.15%
2015โ‚น112.29 B
2013โ‚น233.08 B33.52%
2012โ‚น174.56 B-4.65%
2011โ‚น183.08 B45.53%
2010โ‚น125.80 B